A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus

Clinical trial NCT03334058 · COMPLETED

Trial details

NCT number: NCT03334058
Sponsor: argenx
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pemphigus Vulgaris Pemphigus Foliaceus

Start date: 2017-10-18
Primary completion: 2020-10-28
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.